FOXC2 and colorectal carcinoma: Our investigation revealed the oncogenic role of FOXC2-AS1 through increased intracellular Ca2+ levels and promoted FA formation in CRC, and implied FOXC2-AS1 as a latent prognostic marker and therapeutic target for CRC.